BackgroundCheck.run
Search For

Jason M Goldstein, 512224 Druid Oaks NE, Atlanta, GA 30329

Known as:
Jason Marc Goldstein Jason More Goldstein Jason Goldstien
Related to:
Shifra J Perlman 77

Jason Goldstein Phones & Addresses

Atlanta, GA   

1420 El Camino Real, Burlingame, CA 94010    650-3434471   

704 Willivee Dr, Decatur, GA 30033    678-7052353   

San Francisco, CA   

547 Woodland Hills Dr, Athens, GA 30606    706-5493219   

Education

School / High School: Suffolk University Law School

Ranks

Licence: New York - Currently registered Date: 2012
Get Report
Control this profile

Mentions for Jason M Goldstein

Career records & work history

Lawyers & Attorneys

Jason Goldstein Photo 1

Jason Aaron Goldstein - Lawyer

Licenses:
New York - Currently registered 2012
Education:
Suffolk University Law School

Medicine Doctors

Jason H. Goldstein

Specialties:
Pediatrics, Adolescent Medicine
Work:
Pavilion Pediatrics
10755 Fls Rd STE 260, Lutherville Timonium, MD 21093
410-5832955 (phone)
Site
Education:
Medical School
Johns Hopkins University School of Medicine
Graduated: 2001
Procedures:
Destruction of Benign/Premalignant Skin Lesions, Vaccine Administration
Conditions:
Acute Bronchitis, Acute Pharyngitis, Acute Sinusitis, Acute Upper Respiratory Tract Infections, Hearing Loss, Lyme Disease, Otitis Media, Undescended and Retractile Testicle, Abdominal Hernia, Acute Conjunctivitis, Allergic Rhinitis, Anemia, Anxiety Phobic Disorders, Atopic Dermatitis, Attention Deficit Disorder (ADD), Autism, Bacterial Pneumonia, Bronchial Asthma, Burns, Chronic Sinusitis, Cleft Palate and Cleft Lip, Congenital Anomalies of the Heart, Constipation, Croup, Cystic Fibrosis (CF, Deviated Nasal Septum, Eating Disorders, Epilepsy, Hemolytic Anemia, Infectious Mononucleosis, Inguinal Hernia, Plantar Warts, Pneumonia, Skin and Subcutaneous Infections, Tempromandibular Joint Disorders (TMJ), Urinary Incontinence, Ventral Hernia
Languages:
English
Description:
Dr. Goldstein graduated from the Johns Hopkins University School of Medicine in 2001. He works in Lutherville-Timonium, MD and specializes in Pediatrics and Adolescent Medicine. Dr. Goldstein is affiliated with Greater Baltimore Medical Center.

Jason Goldstein resumes & CV records

Resumes

Jason Goldstein Photo 37

Immunochemistry And Cellular Development Team Leader At Centers For Disease Control

Position:
Immunochemistry and Cellular Development Team Leader at Centers for Disease Control
Location:
Greater Atlanta Area
Industry:
Biotechnology
Work:
Centers for Disease Control - National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)/ CDC since Jan 2006
Immunochemistry and Cellular Development Team Leader Bay Pointe Consulting Jun 2005 - Jan 2006
Scientific and Regulatory Consultant Elan Pharmaceuticals Nov 2001 - Dec 2005
Scientist
Education:
The University of Georgia 1996 - 2001
PhD, Biochemistry, Biophysics and Molecular Biology The University of Georgia 1992 - 1996
Bachelor of Science (BS), Biochemistry and Molecular Biology
Jason Goldstein Photo 38

Pr Intern At Powerslave Records

Position:
PR Intern at Powerslave Records
Location:
San Francisco Bay Area
Industry:
Music
Work:
Powerslave Records
PR Intern
Education:
San Jose State University 2003 - 2007
Jason Goldstein Photo 39

Pr Intern At Powerslave Media Corp

Position:
PR Intern at Powerslave Media Corp
Location:
San Francisco Bay Area
Industry:
Music
Work:
Powerslave Media Corp
PR Intern
Education:
San Jose State University 2003 - 2007

Publications & IP owners

Us Patents

Truncated Fragments Of Alpha-Synuclein In Lewy Body Disease

US Patent:
7306945, Dec 11, 2007
Filed:
Oct 19, 2004
Appl. No.:
10/969335
Inventors:
Tamie J Chilcote - San Francisco CA, US
Jason Goldstein - Burlingame CA, US
John P Anderson - San Francisco CA, US
Wei Ping Gai - Hazelwood Park, AU
Assignee:
Elan Pharmaceuticals, Inc. - South San Francisco CA
The Trustees of Flinders University - Adelaide
International Classification:
C12N 15/00
C12P 21/06
C12Q 1/00
C07K 14/00
US Classification:
435440, 435 691, 435 4, 530350
Abstract:
The application identifies fragments of alpha-synuclein in patients with Lewy Body Disease (LBD) and transgenic animal models thereof. These diseases are characterized by aggregations of alpha-synuclein. The fragments have a truncated C-terminus relative to full-length alpha-synuclein. Some fragments are characterized by a molecular weight of about 12 kDa as determined by SDS gel electrophoresis in tricine buffer and a truncation of at least ten contiguous amino acids from the C-terminus of natural alpha-synuclein. The site of cleavage preferably occurs after residue 117 and before residue 126 of natural alpha-synuclein. The identification of these novel fragments of alpha-synuclein has a number of application in for example, drug discovery, diagnostics, therapeutics, and transgenic animals.

Truncated Fragments Of Alpha-Synuclein In Lewy Body Disease

US Patent:
7358331, Apr 15, 2008
Filed:
Jul 29, 2005
Appl. No.:
11/194115
Inventors:
Tamie J Chilcote - San Francisco CA, US
Jason Goldstein - Doraville GA, US
John P Anderson - San Francisco CA, US
Donald Walker - Pleasant Hill CA, US
Assignee:
Elan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
C07K 14/00
C12P 21/06
C12N 15/00
A61K 38/00
US Classification:
530300, 530350, 435 691, 435440, 514 2, 514 12
Abstract:
The application identifies novel fragments of alpha-synuclein in patients with Lewy Body Disease (LBD) and transgenic animal models thereof. These diseases are characterized by aggregations of alpha-synuclein. The fragments have a truncated C-terminus relative to full-length alpha-synuclein. Some fragments are characterized by a molecular weight of about 12 kDa as determined by SDS gel electrophoresis in tricine buffer and a truncation of at least ten contiguous amino acids from the C-terminus of natural alpha-synuclein. The site of cleavage preferably occurs after residue 117 and before residue 126 of natural alpha-synuclein. The identification of these novel fragments of alpha-synuclein has a number of application in for example, drug discovery, diagnostics, therapeutics, and transgenic animals.

Alpha-Synuclein Kinase

US Patent:
7553639, Jun 30, 2009
Filed:
Jan 30, 2007
Appl. No.:
11/669093
Inventors:
Tami J. Chilcote - San Francisco CA, US
Kelly Banducci - Pleasanton CA, US
Guriqbal S. Basi - Palo Alto CA, US
John P. Anderson - San Francisco CA, US
Jason Goldstein - Decatur GA, US
David Chereau - San Mateo CA, US
Assignee:
Elan Pharma International Limited - Monksland, Athlone, County Westmeath
International Classification:
C12P 21/06
C07K 14/00
US Classification:
435 691, 4353201, 4352523, 536 231, 530350
Abstract:
The invention provides agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient. Preferred agents include inhibitors of PLK2 and GRK6 kinases.

Alpha-Synuclein Kinase

US Patent:
8148089, Apr 3, 2012
Filed:
Feb 8, 2010
Appl. No.:
12/702201
Inventors:
John P. Anderson - San Francisco CA, US
Kelly Banducci - Pleasanton CA, US
Guriqbal S. Basi - Palo Alto CA, US
David Chereau - San Mateo CA, US
Tamie J. Chilcote - San Francisco CA, US
Jason Goldstein - Burlingame CA, US
Irene Griswold - San Francisco CA, US
Assignee:
Elan Pharma International Limited - Dublin
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
The invention provides agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient. Preferred agents include inhibitors of PLK2 kinase.

Alpha-Synuclein Kinase

US Patent:
2008030, Dec 4, 2008
Filed:
Feb 13, 2008
Appl. No.:
12/030849
Inventors:
John P. Anderson - San Francisco CA, US
Kelly Banducci - Pleasanton CA, US
Guriqbal S. Basi - Palo Alto CA, US
David Chereau - San Mateo CA, US
Tamie J. Chilcote - San Francisco CA, US
Jason Goldstein - Decatur GA, US
Assignee:
ELAN PHARMACEUTICALS, INC. - South San Francisco CA
International Classification:
A61K 31/70
C12N 5/06
A61K 31/44
A61K 31/415
A61K 31/47
A61K 31/40
C12Q 1/48
A01K 67/027
A61P 25/00
US Classification:
514 44, 435375, 514339, 514338, 514394, 514312, 514414, 435 15, 800 3
Abstract:
The invention provides agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient. Preferred agents include inhibitors of PLK2 kinase.

Truncated Fragments Of Alpha-Synuclein In Lewy Body Disease

US Patent:
2009003, Feb 5, 2009
Filed:
Feb 29, 2008
Appl. No.:
12/040739
Inventors:
Tamie J. Chilcote - San Francisco CA, US
Jason Goldstein - Burlingame CA, US
John P. Anderson - San Francisco CA, US
Donald Walker - Pleasant Hill CA, US
Assignee:
Elan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A61K 49/00
G01N 33/00
A01K 67/027
A61K 38/00
C12N 9/50
A61P 25/00
A61K 39/395
C12Q 1/02
C07K 16/18
US Classification:
424 91, 436 86, 800 3, 800 9, 435 29, 5303879, 5303873, 514 12, 4241391, 435219
Abstract:
The application identifies novel fragments of alpha-synuclein in patients with Lewy Body Disease (LBD) and transgenic animal models thereof. These diseases are characterized by aggregations of alpha-synuclein. The fragments have a truncated C-terminus relative to full-length alpha-synuclein. Some fragments are characterized by a molecular weight of about 12 kDa as determined by SDS gel electrophoresis in tricine buffer and a truncation of at least ten contiguous amino acids from the C-terminus of natural alpha-synuclein. The site of cleavage preferably occurs after residue 117 and before residue 126 of natural alpha-synuclein. The identification of these novel fragments of alpha-synuclein has a number of application in for example, drug discovery, diagnostics, therapeutics, and transgenic animals.

Alpha-Synuclein Kinase

US Patent:
2011020, Aug 25, 2011
Filed:
Feb 13, 2009
Appl. No.:
12/865857
Inventors:
John P. Anderson - San Francisco CA, US
Kelly Banducci - Pleasanton CA, US
Guriqbal S. Basi - Palo Alto CA, US
David Chereau - San Mateo CA, US
Tamie J. Chilcote - San Fancisco CA, US
Jason Goldstein - Decatur GA, US
International Classification:
C12Q 1/48
C12N 5/071
A61K 31/7105
A61P 25/28
US Classification:
514 44 A, 435 15, 435375
Abstract:
Agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient are provided. Preferred agents include inhibitors of PLK2 kinase.

Antibodies To Alpha Synuclein

US Patent:
2013007, Mar 21, 2013
Filed:
Sep 5, 2012
Appl. No.:
13/604441
Inventors:
Tamie J. Chilcote - San Francisco CA, US
Jason Goldstein - Burlingame CA, US
John P. Anderson - San Francisco CA, US
Donald Walker - Pleasant Hill CA, US
Assignee:
Elan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
C07K 16/18
US Classification:
5303873, 5303879
Abstract:
The application identifies novel fragments of alpha-synuclein in patients with Lewy Body Disease (LBD) and transgenic animal models thereof. These diseases are characterized by aggregations of alpha-synuclein. The fragments have a truncated C-terminus relative to full-length alpha-synuclein. Some fragments are characterized by a molecular weight of about 12 kDa as determined by SDS gel electrophoresis in tricine buffer and a truncation of at least ten contiguous amino acids from the C-terminus of natural alpha-synuclein. The site of cleavage preferably occurs after residue 117 and before residue 126 of natural alpha-synuclein. The identification of these novel fragments of alpha-synuclein has a number of application in for example, drug discovery, diagnostics, therapeutics, and transgenic animals.

Amazon

Jason Goldstein Photo 43

Flight Of The Mystic Eagle

Author:
Jason Goldstein-Lee
Publisher:
lulu.com
Binding:
Paperback
Pages:
260
ISBN #:
1430323272
EAN Code:
9781430323273
The stress of our current way of life has led many people to long for peace and harmony. "Flight of the Mystic Eagle" carries the reader on an adventurous journey, which leads, not only to self-discovery, but also to awareness of the unseen forces, which direct our experiences, and tell of the impor...
Jason Goldstein Photo 44

True Dark

Author:
Mark Anthony Crittenden, Lee Hughes, Caitlin Hoffman, Marge B. Simon, Richard Godwin, Dorothy Davies, Thomas Kearnes, James S. Dorr, Jason Barney, Nicky Peacock, Ken L. Jones, Christian Larsen, Richard Jay Goldstein, Chris Hertz, John Taylor, Benjamin Sperduto, Jacob Baxter
Publisher:
CreateSpace Independent Publishing Platform
Binding:
Paperback
Pages:
178
ISBN #:
1492242284
EAN Code:
9781492242284
Journey into nightmarish landscapes, into the blackest midnight of your fear...into the True Dark, 17 tales guaranteed to make you sleep with the light on.

Possible Relatives

David Goldstein  Dawn E Goldstein  Deanna J Goldstein  Dale A Goldstein  Debora S Goldstein  Deborah V Goldstein  Danelle M Goldstein  Jason F Last  Jason S Johnson  Jason R Stamps 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.